Se and Rinvoq drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Se (selenium) and Rinvoq (upadacitinib). Common drug interactions include drug ineffective among females and arthralgia among males.
The phase IV clinical study analyzes what interactions people have when they take Se and Rinvoq. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.
What is Se?
Se has active ingredients of selenium. eHealthMe is studying from 5,604 Se users. Check the latest studies of Se.
What is Rinvoq?
Rinvoq has active ingredients of upadacitinib. eHealthMe is studying from 47,375 Rinvoq users. Check the latest studies of Rinvoq.
19 people who take Se and Rinvoq together, and have interactions are studied.

What are the common drug interactions of Se and Rinvoq, by gender? *:
female:
- Drug ineffective
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Muscle spasms (muscle contraction)
- Acne (skin problems that cause pimples)
- Colitis ulcerative (inflammation of colon with ulcer)
- Skin disorder (skin disease)
- Flatulence (flatus expelled through the anus)
- Osteoarthritis (a joint disease caused by cartilage loss in a joint)
- Cellulitis (infection under the skin)
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
male:
- Arthralgia (joint pain)
- Cough
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Lung disorder (lung disease)
- Respiratory tract irritation
- Urinary tract disorder
- Wheezing (a high-pitched whistling sound made while you breath)
- Fatigue (feeling of tiredness)
- Pain
- Peripheral swelling
What are the common drug interactions of Se and Rinvoq, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Drug ineffective
- Muscle spasms (muscle contraction)
- Acne (skin problems that cause pimples)
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Colitis ulcerative (inflammation of colon with ulcer)
- Skin disorder (skin disease)
- Flatulence (flatus expelled through the anus)
- Rhinalgia (pain in the nose)
- Infection susceptibility increased
40-49:
n/a
50-59:
- Cough
- Dizziness
- Exposure to toxic agent
- Fatigue (feeling of tiredness)
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Low density lipoprotein increased (cholesterol increased in blood)
- Lung disorder (lung disease)
- Pain
- Peripheral swelling
60+:
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Cellulitis (infection under the skin)
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Hepatic enzyme increased
- Hospitalisation
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
- Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
- Pain in extremity
- Pyrexia (fever)
What are the existing conditions these people have? *
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 12 people, 63.16%
- Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 7 people, 36.84%
- Pain: 3 people, 15.79%
- Stomatitis (inflammation of mucous membrane of mouth): 2 people, 10.53%
- Back Pain: 2 people, 10.53%
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 10.53%
- Cellulitis (infection under the skin): 2 people, 10.53%
- Hyperhidrosis (abnormally increased sweating): 2 people, 10.53%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 10.53%
- Impaired Gastric Emptying: 2 people, 10.53%
* Approximation only. Some reports may have incomplete information.
Do you take Se and Rinvoq?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Se and Rinvoq:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Se:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Rinvoq:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Se and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rinvoq and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on selenium and upadacitinib (the active ingredients of Se and Rinvoq, respectively), and Se and Rinvoq (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Clarithromycin and Effexor Xr - 7 seconds ago
- Could Kenalog-40 cause Nervousness? - 11 seconds ago
- Could Actonel cause Sacroiliitis? - 32 seconds ago
- Drug interactions of Rabeprazole Sodium and Intelence - a minute ago
- Could Revatio cause Restless Leg Syndrome? - a minute ago
- Acute Lymphocytic Leukemia (All) and Dehydration - a minute ago
- Drug interactions of Lasix and Juluca - 2 minutes ago
- How effective is Tegretol for Depression? - 2 minutes ago
- Drug interactions of Escitalopram Oxalate and Zide - 2 minutes ago
- Drug interactions of Triamcinolone Acetonide and Naproxen - 3 minutes ago